Lord Justice Birss speaking at LSPN Europe 2024

2 July 2025NewsEuropeSarah Speight

Lord Justice Birss to become chancellor of the High Court

The prominent senior IP judge is known for his groundbreaking judgments on patents, AI and FRAND, such as Unwired Planet, Thaler's DABUS, and InterDigital.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

UK court upholds EU SPC precedent, rejecting MSD’s appeal

30 January 2025 UK court confirms it cannot depart from CJEU law | SPC application for multiple sclerosis treatment rejected | Judges stress that any change to the SPC framework needs legislative reform not interpretation.

Biotechnology

Five minutes with… Penny Gilbert

9 March 2021 The fallout from the landmark Regeneron v Kymab is still being weighed by the UK life sciences community.

Accord loses patent invalidation battle at English court

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High Court.

More on this story

UK court upholds EU SPC precedent, rejecting MSD’s appeal

30 January 2025 UK court confirms it cannot depart from CJEU law | SPC application for multiple sclerosis treatment rejected | Judges stress that any change to the SPC framework needs legislative reform not interpretation.

Biotechnology

Five minutes with… Penny Gilbert

9 March 2021 The fallout from the landmark Regeneron v Kymab is still being weighed by the UK life sciences community.

Accord loses patent invalidation battle at English court

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High Court.

More on this story

UK court upholds EU SPC precedent, rejecting MSD’s appeal

30 January 2025 UK court confirms it cannot depart from CJEU law | SPC application for multiple sclerosis treatment rejected | Judges stress that any change to the SPC framework needs legislative reform not interpretation.

Biotechnology

Five minutes with… Penny Gilbert

9 March 2021 The fallout from the landmark Regeneron v Kymab is still being weighed by the UK life sciences community.

Accord loses patent invalidation battle at English court

8 November 2017 Generic drugs maker Accord Healthcare has lost a battle to have a patent invalidated at the English High Court.

More features

Bankruptcy judge approves $305m sale of genetics testing company

Sanofi successfully challenges rare disease patent in Europe

Bayer appoints new head of IP

WATCH: Policy direction—where are we now?

Broad Institute wins appeal to restore CRISPR patent in Europe

BMS faces fresh lawsuit over alleged cancer drug monopoly

WATCH: Synergy in science—navigating the landscape of pharmaceutical collaborations

Boies Schiller Flexner adds three-strong litigation team